Physician profile
Stephen Covington
NPI 1063944080
$3,562.88
in general payments reported to CMS, 2019-2025
10 companies · $423 in 2025
The $423 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,390 · 2022: $1,137 · 2023: $429 · 2024: $183 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,507.18 | 2021-2023 | Senza |
| Abbott Laboratories | $972.69 | 2021-2023 | Octrode |
| Medtronic, INC. | $711.27 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Averitas Pharma INC. | $121.94 | 2023 | Qutenza |
| Boston Scientific Corporation | $58.37 | 2025 | Wavewriter Alpha Prime 16, Intracept |
| Ethicon US, LLC | $56.33 | 2021 | |
| Biotronik Nro, INC. | $46.13 | 2025 | Prospera |
| Stryker Corporation | $33.67 | 2022 | |
| Spr Therapeutics, INC | $32.46 | 2021 | |
| Globus Medical, INC. | $22.84 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Covington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.